Tickers — A

175 tickers
Ranks this page's recent reports by score.
ACI Worldwide, Inc.
ACIW·Technology
A ★★★★Buy
Current$56.34
Target$63.00
Return+11.8%
Nov 1, 2026

ACI Worldwide combines mission-critical payment software, recurring cash flow, and real-time payments growth opportunities at a reasonable valuation, although bookings volatility and Biller margin pressure could constrain earnings expansion.

Score
78
Arrow Electronics, Inc.
ARW·Technology
B ★★★Hold
Current$208.34
Target$225.00
Return+8.0%
Nov 1, 2026

Arrow Electronics combines global distribution scale, improving semiconductor demand, and disciplined capital allocation, but cyclical earnings, working-capital exposure, and a reduced valuation cushion constrain near-term upside.

Score
71
Advanced Energy Industries, Inc.
AEIS·Industrials
B ★★★Hold
Current$222.06
Target$295.26
Return+33.0%
Nov 1, 2026

Advanced Energy benefits from rising semiconductor complexity and AI data-center power demand, with strong earnings recovery potential, but elevated investment spending, dilution, and uncertain cash conversion constrain the upside.

Score
67
Aptiv PLC
APTV·Consumer Discretionary
B ★★★Hold
Current$43.93
Target$58.23
Return+32.6%
Nov 1, 2026

Aptiv offers a potentially attractive post-spin recovery through higher-value automotive electronics and low forward earnings valuation, but weak cash conversion and cyclical vehicle demand remain significant obstacles.

Score
65
Aflac Incorporated
AFL·Financials
B ★★★Hold
Current$123.89
Target$121.92
Return-1.6%
Nov 1, 2026

Aflac offers durable supplemental insurance franchises, strong adjusted returns on equity, and disciplined shareholder distributions, but mature Japanese demand, U.S. claims pressure, and demanding valuation limit near-term upside.

Score
66
American Homes 4 Rent
AMH·Real Estate
A ★★★★Buy
Current$31.60
Target$34.68
Return+9.7%
Nov 1, 2026

American Homes 4 Rent combines resilient rental income, a covered dividend and development-driven FFO growth at a reasonable valuation, although regional housing oversupply and financing costs could constrain returns.

Score
75
Alignment Healthcare, Inc.
ALHC·Healthcare
C ★★Sell
Current$7.27
Nov 1, 2026

Alignment Healthcare has substantial long-term Medicare Advantage growth potential through differentiated senior-care delivery, but worsening medical costs and reduced profit guidance threaten the conversion of membership gains into durable earnings.

Score
58
Allegro MicroSystems, Inc.
ALGM·Technology
B ★★★Hold
Current$30.53
Target$37.20
Return+21.8%
Nov 1, 2026

Allegro MicroSystems can benefit from expanding demand for specialized sensing and power semiconductors, but cyclical automotive exposure, intense competition, and demanding cash-flow valuation limit its margin of safety.

Score
70
Alnylam Pharmaceuticals, Inc.
ALNY·Healthcare
B ★★★Hold
Current$165.00
Target$246.28
Return+49.3%
Nov 1, 2026

Alnylam combines a differentiated RNAi platform, substantial ATTR growth potential, and positive cash flow at a more attractive valuation, but slower AMVUTTRA demand conversion and reimbursement risks threaten the pace of future expansion.

Score
72
Ambev S.A.
ABEV·Consumer Staples
S ★★★★★Strong Buy
Current$2.66
Target$3.00
Return+12.8%
Nov 1, 2026

Ambev combines dominant beverage brands, strong cash generation, and attractive valuation with meaningful shareholder returns, although Brazilian currency volatility and mature beer demand constrain its growth potential.

Score
86
APi Group Corporation
APG·Industrials
C ★★Sell
Current$44.34
Nov 1, 2026

APi Group benefits from durable fire-safety demand and strong organic growth, but elevated valuation expectations and acquisition-related leverage weaken its near-term investment appeal.

Score
63
ASE Technology Holding Co., Ltd.
ASX·Technology
D ★Strong Sell
Current$39.50
Nov 1, 2026

ASE Technology Holding benefits from structural advanced packaging demand and improving semiconductor margins, but elevated valuation and exceptionally heavy capital spending threaten future shareholder returns.

Score
53